Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)

View source ↗

Summary

FDA approved a supplemental application for trifluoperazine hydrochloride by Sandoz Inc., authorizing its generic formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIFLUOPERAZINE HYDROCHLORIDE (trifluoperazine hydrochloride)

Snippet

SUPPL AP for TRIFLUOPERAZINE HYDROCHLORIDE (TRIFLUOPERAZINE HYDROCHLORIDE)